April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Melanocortin Receptor Stimulation Induces CD4+CD25+NRP-1- Treg cells to Suppress Experimental Autoimmune Uveitis
Author Affiliations & Notes
  • Darren J Lee
    Ophthalmology, Boston University School of Med, Boston, MA
  • Andrew W Taylor
    Ophthalmology, Boston University School of Med, Boston, MA
  • Footnotes
    Commercial Relationships Darren Lee, None; Andrew Taylor, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3574. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Darren J Lee, Andrew W Taylor; Melanocortin Receptor Stimulation Induces CD4+CD25+NRP-1- Treg cells to Suppress Experimental Autoimmune Uveitis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3574.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: IRBP-specific regulatory immunity is found in the spleen of mice that have recovered from experimental autoimmune uveoretinitis (EAU). This post-EAU regulatory immunity requires post-EAU Treg cells to be activated through the adenosine 2A receptor (A2Ar) by melanocortin 5 receptor expressing (MC5r) regulatory post-EAU APC. The ligand for MC5r, α-melanocyte stimulating hormone (α-MSH), induces a regulatory APC that promotes Treg cell activation. Neuropilin-1 (NRP-1) has been reported to distinguish between inducible (iTreg) or natural (nTreg) nTreg cells. It is not known whether the post-EAU Treg cells are iTreg or nTreg cells. This work shows that the α-MSH induced regulatory APC promotes CD4+CD25+ Treg cells that are NRP-1-.

Methods: C57BL/6 (WT) and A2Ar(-/-) mice were immunized with IRBPp 1-20 in CFA to induce EAU. Spleen T cells from WT and A2Ar(-/-) post-EAU mice were re-stimulated with IRBP for 48 hours, stained for CD4, CD25, and NRP-1, analyzed by flow cytometry, and sorted T cells were transferred into recipient EAU mice. WT APC from unimmunized mice were collected from the spleen, treated with α-MSH for 48 hours, washed, and used to activate IRBP-specific primed T cells. These T cells were stained for the above markers and assessed for regulatory activity by adoptive transfer of sorted NRP-1- and NRP-1+CD4+CD25- T cells into mice immunized for EAU.

Results: EAU duration and severity was nearly identical in WT and A2Ar(-/-) mice; however, post-EAU A2Ar(-/-) mice lacked regulatory immunity in their spleens. Also, they had significantly less NRP-1- T cells in their spleens compared to T cells from WT post-EAU mice. Transfer of sorted NRP-1- T cells activated by α-MSH treated APC suppressed EAU in recipient mice. In contrast, mice that received sorted WT NRP-1+ T cells, A2Ar(-/-) NRP-1+, or A2Ar(-/-) NRP-1- T cells showed a similar course of disease compared to untreated mice.

Conclusions: The A2Ar-dependent post-EAU Treg cell is CD4+ CD25+ NRP-1-. Therefore, as EAU resolves the melanocortin-mediated regulatory APC activates a protective ocular autoantigen-specific iTreg cell.

Keywords: 555 immunomodulation/immunoregulation • 553 immune tolerance/privilege • 746 uveitis-clinical/animal model  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.